Thomas Delate

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi request reprint Positive predictive values of ICD-9 codes to identify patients with stroke or TIA
    Kari L Olson
    16601 E Centretech Parkway, Aurora, CO 80011 E mail
    Am J Manag Care 20:e27-34. 2014
  2. pmc Out-of-plan pharmacy use by members of a managed care organization
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
    Perm J 16:15-21. 2012
  3. pmc Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    Cancer Epidemiol Biomarkers Prev 21:673-80. 2012
  4. pmc Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer
    Thomas Delate
    Clinical Pharmacy Research Scientist, Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, Colorado 80011, USA
    Oncologist 17:419-27. 2012
  5. doi request reprint Reduced health care expenditures after enrollment in a collaborative cardiac care service
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 30:1127-35. 2010
  6. ncbi request reprint Effect of patient notification of formulary change on formulary adherence
    Thomas Delate
    Kaiser Permanente of Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    J Manag Care Pharm 11:493-8. 2005
  7. doi request reprint Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding
    Daniel M Witt
    Clinical Pharmacy Research Team, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Arch Intern Med 172:1484-91. 2012
  8. doi request reprint Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressure
    Karen J McConnell
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado, USA
    Pharmacotherapy 31:1063-72. 2011
  9. ncbi request reprint Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study
    Amy B Kauffman
    Kaiser Permanente Colorado, Aurora, Colorado, USA
    Clin Drug Investig 28:501-7. 2008
  10. doi request reprint Factors associated with recurrent coronary events among patients with cardiovascular disease
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 29:906-13. 2009

Detail Information

Publications54

  1. ncbi request reprint Positive predictive values of ICD-9 codes to identify patients with stroke or TIA
    Kari L Olson
    16601 E Centretech Parkway, Aurora, CO 80011 E mail
    Am J Manag Care 20:e27-34. 2014
    ..54 for identifying confirmed history of stroke or transient ischemic attack (cerebral event) among patients within a managed care organization...
  2. pmc Out-of-plan pharmacy use by members of a managed care organization
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
    Perm J 16:15-21. 2012
    ..Little is known about the use of these programs. The purpose of this study was to assess the rate and characteristics of prescriptions written in a managed care organization (MCO) to an out-of-plan pharmacy (OOPP)...
  3. pmc Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    Cancer Epidemiol Biomarkers Prev 21:673-80. 2012
    ..However, information on VDW chemotherapy data validity is limited. The purpose of this study was to assess the validity of VDW chemotherapy data...
  4. pmc Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer
    Thomas Delate
    Clinical Pharmacy Research Scientist, Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, Colorado 80011, USA
    Oncologist 17:419-27. 2012
    ..This analysis assessed the first-line treatment strategies for VTE in patients with advanced solid tumors...
  5. doi request reprint Reduced health care expenditures after enrollment in a collaborative cardiac care service
    Thomas Delate
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 30:1127-35. 2010
    ..To assess the impact of a collaborative cardiovascular risk reduction service (Collaborative Cardiac Care Service [CCCS]) on total health care expenditures after an incident acute coronary event...
  6. ncbi request reprint Effect of patient notification of formulary change on formulary adherence
    Thomas Delate
    Kaiser Permanente of Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    J Manag Care Pharm 11:493-8. 2005
    ..To evaluate the impact of patient notification of impending formulary changes on formulary adherence...
  7. doi request reprint Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding
    Daniel M Witt
    Clinical Pharmacy Research Team, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Arch Intern Med 172:1484-91. 2012
    ..The objective of this study was to determine the incidence of thrombosis, recurrent GIB, and death, as well as the time to resumption of anticoagulant therapy, during the 90 days following a GIB event...
  8. doi request reprint Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressure
    Karen J McConnell
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado, USA
    Pharmacotherapy 31:1063-72. 2011
    ....
  9. ncbi request reprint Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study
    Amy B Kauffman
    Kaiser Permanente Colorado, Aurora, Colorado, USA
    Clin Drug Investig 28:501-7. 2008
    ....
  10. doi request reprint Factors associated with recurrent coronary events among patients with cardiovascular disease
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 29:906-13. 2009
    ..To determine which factors are associated with recurrent coronary events...
  11. ncbi request reprint Outcomes of patients discharged from pharmacy-managed cardiovascular disease management
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Am J Manag Care 15:497-503. 2009
    ..To evaluate whether patients with coronary artery disease (CAD) discharged from the Clinical Pharmacy Cardiac Risk Service (CPCRS) would maintain their lipid goals with use of an electronic laboratory reminder system...
  12. doi request reprint Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes
    Daniel M Witt
    Kaiser Permanente Colorado, Aurora, CO University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver, CO Electronic address
    Thromb Res 132:770-5. 2013
    ..We aimed to define the impact of warfarin on ICH incidence rates and to identify baseline clinical characteristics of patients who experienced ICH and factors associated with fatal ICH...
  13. ncbi request reprint Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service
    Samuel G Johnson
    Kaiser Permanente of Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    Chest 131:1500-7. 2007
    ....
  14. doi request reprint Outcomes associated with combined antiplatelet and anticoagulant therapy
    Samuel G Johnson
    Kaiser Permanente Colorado Region, Clinical Pharmacy Services, Aurora, CO 80011, USA
    Chest 133:948-54. 2008
    ..The objective of this study was to estimate and compare the incidence of adverse and coronary event rates between patients receiving warfarin monotherapy or warfarin and antiplatelet combination therapy...
  15. doi request reprint Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Kari L Olson
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
    J Thromb Thrombolysis 29:316-21. 2010
    ..0; 95% CI 1.1-3.8). Post-stent treatment with warfarin, ASA, and clopidogrel was associated with a substantially greater likelihood of major hemorrhage than treatment with ASA and clopidogrel alone...
  16. ncbi request reprint Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty
    Nathan P Clark
    Clinical Pharmacy Anticoagulation and Anemia Services, Kaiser Permanente Colorado, Aurora, CO, USA
    Thromb Res 131:390-5. 2013
    ..The updated guidelines include low-intensity warfarin as a recommended option, but data evaluating this intervention has not kept pace with newer agents...
  17. doi request reprint Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study
    Nathan P Clark
    Clinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, 280 Exempla Circle, Lafayette, CO 80026, USA
    Pharmacotherapy 28:960-7. 2008
    ..To quantify the absolute risk of thromboembolism associated with a significant subtherapeutic international normalized ratio (INR) in patients with previously stable anticoagulation while receiving warfarin...
  18. ncbi request reprint Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience
    Debra P Ritzwoller
    The Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon Division of Research, Kaiser Permanente Northern California, Oakland, California The Group Health Research Institute, Seattle, Washington Fred Hutchinson Cancer Research Center, Seattle, Washington and Department of Oncology, Kaiser Permanente Colorado, Denver, Colorado
    J Thorac Oncol 9:692-701. 2014
    ..However, subgroup analyses of this and other studies have suggested variable results by age and gender...
  19. doi request reprint Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring
    Brandon J Simmons
    Clinical Pharmacy Anticoagulation Service, Aurora, Colorado 80011, USA
    Pharmacotherapy 32:1078-84. 2012
    ....
  20. ncbi request reprint Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system
    Beverly A Kroner
    Chief of Primary Care Clinical Pharmacy Services, Kaiser Permanente, Colorado Region, Aurora, CO 80011, USA
    J Manag Care Pharm 14:155-63. 2008
    ..Validation of cost-avoidance projections is also difficult because traditional projection methods have several limitations...
  21. ncbi request reprint Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation
    Thomas Delate
    Kaiser Permanente Colorado, 16601 E Centretech Pkwy, Aurora, CO 80011, USA
    Chest 131:816-22. 2007
    ..This study describes the rate of falsely elevated INRs and characteristics predictive of falsely elevated INRs...
  22. doi request reprint A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services
    Robin R Hill
    Department of Pharmacy, Kaiser Permanente, Aurora, CO 80014, USA
    J Thromb Thrombolysis 27:334-9. 2009
    ..To describe and compare warfarin therapy use and outcomes between warfarin-receiving patients in hospice or palliative care (HPC) and not in HPC...
  23. doi request reprint Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial
    Mary Beth Dowd
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente, Aurora, CO, USA
    J Thromb Thrombolysis 31:472-7. 2011
    ....
  24. doi request reprint Impact of an automated dispensing system in outpatient pharmacies
    Tammy L Humphries
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011 9045, USA
    J Am Pharm Assoc (2003) 48:774-9. 2008
    ..To evaluate the impact of an automated dispensing system (ADS) on pharmacy staff work activities and job satisfaction...
  25. pmc Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network
    Debra P Ritzwoller
    Institute for Health Research, Kaiser Permanente Colorado, 10065 E Harvard Avenue, Suite 300, Denver, CO 80231, USA
    Lung Cancer 78:245-52. 2012
    ..However, little is known about variation in first-line NSCLC chemotherapy use in younger patients, health maintenance organization (HMO)-based settings, and for high-cost, novel agents, such as bevacizumab and erlotinib...
  26. doi request reprint Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations
    Sarah J Billups
    School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 18:253-7. 2009
    ..To quantify the effect of clinical and demographic factors on the risk of elevated and toxic tricyclic antidepressant (TCA) plasma concentrations (Cp) and to describe the rates of elevated and toxic TCA Cp...
  27. doi request reprint Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
    Amy B Kauffman
    Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
    J Clin Lipidol 4:173-80. 2010
    ..This study evaluated the extent to which this recommendation can be attained by the use of currently available lipid-lowering therapies...
  28. doi request reprint Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy
    Nathan P Clark
    Clinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, 280 Exempla Circle, Lafayette, Colorado, USA
    Thromb Res 125:402-5. 2010
    ..3-0.7 u/ml during pregnancy. The objective of this study was to describe UFH doses and monitoring strategies required to achieve and maintain therapeutic anti-Xa intensity in a cohort of women treated with UFH during pregnancy...
  29. doi request reprint Assessment of the association between colchicine therapy and serious adverse events
    Brittany A Todd
    Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 32:974-80. 2012
    ....
  30. doi request reprint Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility
    Thomas Delate
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011, USA
    Pharmacotherapy 28:444-52. 2008
    ..To assess the impact of a pilot pharmacist-managed medication reconciliation program on mortality and use of health care services in patients discharged to home from a skilled nursing facility (SNF)...
  31. doi request reprint A descriptive evaluation of unfractionated heparin use during pregnancy
    Nathan P Clark
    Clinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, Lafayette, CO 80026, USA
    J Thromb Thrombolysis 27:267-73. 2009
    ..Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) do not cross the placenta and have demonstrated utility in the prevention and treatment of thrombosis during pregnancy...
  32. doi request reprint Injury in an elderly population before and after initiating a skeletal muscle relaxant
    Sarah J Billups
    Kaiser Permanente, Aurora, CO, USA
    Ann Pharmacother 45:485-91. 2011
    ..Quality guidelines recommend avoidance of skeletal muscle relaxants in patients 65 years and older, but this recommendation is based on expert opinion, not evidence...
  33. doi request reprint Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy
    Nathan P Clark
    Clinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, Lafayette, Colorado, USA
    Pharmacotherapy 30:369-74. 2010
    ..To describe unfractionated heparin (UFH) dosing requirements and monitoring parameters to achieve target antifactor Xa concentrations in pregnant women receiving intermediate-dose UFH therapy...
  34. ncbi request reprint Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease
    John A Merenich
    Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA
    Pharmacotherapy 27:1370-8. 2007
    ..To determine the effect of early and sustained enrollment in a comprehensive cardiac care (CCC) program on all-cause mortality in patients with coronary artery disease (CAD)...
  35. doi request reprint Clinical pharmacists' role in improving osteoporosis treatment rates among elderly patients with untreated atraumatic fractures
    T Ann Nadrash
    Kaiser Permanente Colorado Arapahoe Medical Office, Centennial, CO 80122, USA
    Ann Pharmacother 42:334-40. 2008
    ..Missed opportunities for osteoporosis detection and treatment following fractures, especially in the elderly, are common. Clinical pharmacy specialist (CPS) intervention may positively impact this deficiency...
  36. doi request reprint Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
    Daniel M Witt
    Kaiser Permanente Colorado Clinical Pharmacy Anticoagulation Service, Lafayette, USA
    Blood 114:952-6. 2009
    ..0 or higher or chronic diseases. We hypothesize that many patients demonstrating stable INR control could be safely treated with INR recall intervals greater than the traditional 4 weeks...
  37. doi request reprint Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, Colorado 80237, USA
    Med Care 46:1116-22. 2008
    ..Information on the effects of reaching the Medicare Part D standard drug benefit threshold is limited...
  38. doi request reprint Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit
    Elizabeth A Bayliss
    Institute for Health Research, Kaiser Permanente, Denver, CO, USA
    Med Care 48:267-72. 2010
    ..Medicare Part D beneficiaries who reach the drug benefit threshold (DBT) risk adverse health outcomes...
  39. ncbi request reprint A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension
    Adriane N Irwin
    Kaiser Permanente Colorado, Aurora, CO, United States Electronic address
    Thromb Res 133:790-4. 2014
    ..The purpose of this study was to compare and contrast warfarin therapy monitoring requirements and outcomes in patients with PAH and atrial fibrillation (AF) receiving long-term anticoagulation...
  40. ncbi request reprint Ambulatory clinical pharmacy specialty services: the kaiser permanente colorado experience
    Robin R Hill
    Kaiser Permanente Colorado, 2550 S Parker Rd, Ste 400, Aurora, CO 80014, USA
    J Manag Care Pharm 20:245-53. 2014
    ....
  41. doi request reprint Impact of continuing professional development versus traditional continuing pharmacy education on learning behaviors
    Karen J McConnell
    Pharmacy Department, Kaiser Permanente, Denver, CO, USA
    J Am Pharm Assoc (2003) 52:742-52. 2012
    ..To assess the effect of continuing professional development (CPD) on perceptions of learning behaviors compared with traditional continuing pharmacy education (CPE)...
  42. doi request reprint The impact of continuing professional development versus traditional continuing pharmacy education on pharmacy practice
    Karen J McConnell
    Pharmacy Department, Kaiser Permanente of Colorado, Aurora, USA
    Ann Pharmacother 44:1585-95. 2010
    ..The Institute of Medicine states that the new vision for continuing education (CE) for health-care professionals will be based on continuing professional development (CPD); however, information on the utility of CPD is lacking...
  43. ncbi request reprint A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapy
    Kandace V Anich
    Primary Care Clinical Pharmacy Services, Kaiser Permanente of Colorado, Westminster, CO, USA
    J Thromb Thrombolysis 20:183-8. 2005
    ..Routine monitoring of laboratory tests, such as complete blood counts (CBC), may provide theoretical benefit in this patient population as a means of detecting occult bleeding through hemoglobin values that decrease compared to baseline...
  44. ncbi request reprint Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 26:1333-41. 2006
    ..To assess the effectiveness of a pharmacist-managed service in improving hypertension control among patients with coronary artery disease...
  45. doi request reprint Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold
    Amber Cronk
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011 9045, USA
    Am J Health Syst Pharm 65:1062-70. 2008
    ..The mechanisms used by Medicare beneficiaries who reached their Part D drug-benefit threshold to cope with the costs of prescription drugs were evaluated...
  46. doi request reprint Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries
    Erin K Welch
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, USA
    Ann Pharmacother 43:603-10. 2009
    ....
  47. doi request reprint Evaluation of venous thromboembolism risk following hospitalization
    Sheryl J Herner
    Pharmacy Department, Kaiser Permanente Colorado, Denver, CO, USA
    J Thromb Thrombolysis 32:32-9. 2011
    ..186). Factors associated with a VTE diagnosis included hospitalization for a surgical, medical, or orthopedic indication in the previous 90 days, younger age, longer hospitalization, cancer and an elevated Chronic Disease Score...
  48. ncbi request reprint Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy
    Adriane N Irwin
    Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado, USA
    Pharmacotherapy 33:1175-83. 2013
    ..To quantify the change in weekly warfarin dose after bariatric surgery in patients requiring long-term warfarin therapy...
  49. ncbi request reprint Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches
    Olga E Gershovich
    Kaiser Permanente Colorado, 8383 W Alameda Ave, Lakewood, CO 80226, USA
    J Manag Care Pharm 12:246-53. 2006
    ..This investigation was designed to assess conversion success, migraine drug utilizations, and patient satisfaction with a clinical pharmacist-managed conversion program from sumatriptan to rizatriptan ODT, both formulary drugs...
  50. ncbi request reprint An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy
    Samuel G Johnson
    Clinical Pharmacy Services, Kaiser Permanente of Colorado, Aurora, CO 80011, USA
    J Thromb Thrombolysis 19:209-12. 2005
    ..The purpose of this investigation was to examine the association between glycemic control and therapeutic anticoagulation control...
  51. doi request reprint Clinical outcomes associated with brand-to-generic phenytoin interchange
    Shilpa A Kinikar
    Pharmacy Department, Kaiser Permanente Colorado, Denver, CO, USA
    Ann Pharmacother 46:650-8. 2012
    ..Concerns that antiepileptic brand-to-generic interchange results in disruption of seizure control are widespread. However, little within-patient evidence exists examining such interchanges...
  52. ncbi request reprint Monitoring of patients given second-generation antipsychotic agents
    Kari L Olson
    Psychiatr Serv 57:1045-6. 2006
  53. ncbi request reprint Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population
    Thomas Delate
    Outcomes Research, Express Scripts, Inc, Maryland Heights, MO, USA
    Am J Manag Care 11:29-36. 2005
    ..To examine the clinical and financial outcomes associated with a proton pump inhibitor (PPI) prior-authorization policy...
  54. ncbi request reprint Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002
    Thomas Delate
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Psychiatr Serv 55:387-91. 2004
    ..The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002...